European Heart Journal - Cardiovascular Pharmacotherapy Template
Get your European Heart Journal - Cardiovascular Pharmacotherapy paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4
How to Use the European Heart Journal - Cardiovascular Pharmacotherapy Template | A Step-by-Step Guide
Authored by Sumalatha Gangadhar | Published on 11 August, 2026
Submitting to European Heart Journal - Cardiovascular Pharmacotherapy goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the European Heart Journal - Cardiovascular Pharmacotherapy guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
What is the European Heart Journal - Cardiovascular Pharmacotherapy Template?
It is a manuscript shell aligned to European Heart Journal - Cardiovascular Pharmacotherapy. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the European Heart Journal - Cardiovascular Pharmacotherapy journal page before you draft.
What's actually in an European Heart J Cardiovascular Pharmacotherapy submission:
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the European Heart Journal - Cardiovascular Pharmacotherapy guide for authors lists, and cite figures and tables in order.
What separates a clean submission from one that gets kicked back:
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the European Heart Journal - Cardiovascular Pharmacotherapy guide for authors before you submit.
What does this European Heart Journal - Cardiovascular Pharmacotherapy Template include?
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through Editorial Manager.
Steps to Use This Template with SciSpace Agent
- Click Start Writing on this page. The SciSpace Agent prompt screen opens with the template loaded.
- Use the loaded template, or upload a version your group already uses for European Heart J Cardiovascular Pharmacotherapy.
- Edit the prompt with your topic and article type, and note any requirement from the European Heart Journal - Cardiovascular Pharmacotherapy guide for authors.
- Run the prompt. The agent drafts into the correct structure and reference style.
- Use View Outputs to verify required statements and formatting are present.
- Export and submit through Editorial Manager.
European Heart Journal - Cardiovascular Pharmacotherapy Template Structure at a Glance
| Element | European Heart J Cardiovascular Pharmacotherapy requirement |
|---|---|
| Abstract | Structured abstract with maximum 250 words. The abstract is structured under the headings: (1) aims, (2) methods and results, (3) conclusion. PharmaPulse papers should not have an abstract. Rapid Communications abstracts are not permitted. PharmaPlain papers should not have an abstract |
| Main text | Original articles: maximum 5000 words (including references, figure legends and tables) and a maximum of 50 references. Reviews: maximum 5000 words (excluding references and the text in figure legends and tables). Trial Design Papers: maximum 3000 words (including references, figure legends, and tables) with no more than 50 references. Editorials: maximum 1500 words (including references, figure legends and tables) with a maximum of 15 references. Correspondence/Letters: up to 1000 words (including references, figure legends and tables), up to 1 figure/table and up to 10 references. Current Opinion: maximum 2500 words (including references, figure legends and tables) with up to 20 references. Viewpoint: maximum 1500 words with 15 references and 3 authors. PharmaPulse: maximum 1000 words (including references and text in figure legends) with only 5 references. PharmaPlain: maximum 1000 words (including references and text in figure legends) with only 10 references. Rapid Communications: maximum 1400 words (excluding the title, abstracts, legends, and references) with 10 references |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | No more than six keywords are required. Maximum of 6 keywords/phrases for ESC Official Output |
| References | Vancouver style. References are identified in the text by Arabic numerals and numbered in the order cited. Titles of journals should be abbreviated in accordance with Medline. Complete information should be given for each reference, including title of article, abbreviated journal title and inclusive pagination. If there are more than six authors, the first six authors should be listed followed by 'et al.' |
| Peer review | Single-anonymised (single-blind) peer review process, meaning that the Authors' identities are known to the Editor and the Reviewers, but that the Reviewers' identities are known only to the Editor and are hidden from the Authors |
| Submission | www.editorialmanager.com/ehj-cvp |
Quick Tips for Using the European Heart Journal - Cardiovascular Pharmacotherapy Template
Read the European Heart Journal - Cardiovascular Pharmacotherapy guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to European Heart Journal - Cardiovascular Pharmacotherapy in under a page.
Best Practices
Skim two or three recent European Heart J Cardiovascular Pharmacotherapy papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the European Heart Journal - Cardiovascular Pharmacotherapy journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Before You Submit: Final Check
Do one focused pass against the European Heart Journal - Cardiovascular Pharmacotherapy guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through Editorial Manager.
